Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topiramate in obese patients undergoing total joint arthroplasty
NCT04613024Phase 1Withdrawn
- Sponsor
- Stanford University
- Start
- Jul 2025
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of topiramate in postoperative pain and obesity (2 arms), sponsored by Stanford University. Primary endpoints: Reduction in Opioid Consumption at 3 months and Side Effect Profiles of Topiramate and Gabapentin at 3 months. Planned start Jul 2025; status: withdrawn.
02
Drugs
topiramate
03
Conditions
postoperative painobesity
Beyond the preview
Go deeper on NCT04613024.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04613024.